MCM
McKinley Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-54,216
| Closed | -$5.21M | – | 197 |
|
|
2020
Q3 | $5.21M | Sell |
54,216
-99,884
| -65% | -$9.61M | 0.41% | 71 |
|
|
2020
Q2 | $18.8M | Sell |
154,100
-6,169
| -4% | -$753K | 1.28% | 23 |
|
|
2020
Q1 | $13.9M | Sell |
160,269
-1,492
| -0.9% | -$129K | 1.11% | 32 |
|
|
2019
Q4 | $17.4M | Buy |
161,761
+28,393
| +21% | +$3.05M | 1.13% | 34 |
|
|
2019
Q3 | $12M | Sell |
133,368
-13,617
| -9% | -$1.23M | 0.9% | 46 |
|
|
2019
Q2 | $12.4M | Sell |
146,985
-29,403
| -17% | -$2.48M | 0.79% | 44 |
|
|
2019
Q1 | $15.5M | Buy |
176,388
+3,710
| +2% | +$327K | 1.12% | 33 |
|
|
2018
Q4 | $12.3M | Sell |
172,678
-2,782
| -2% | -$199K | 1% | 37 |
|
|
2018
Q3 | $21.6M | Buy |
175,460
+48,562
| +38% | +$5.97M | 1.37% | 28 |
|
|
2018
Q2 | $12.5M | Buy |
126,898
+1,833
| +1% | +$180K | 0.81% | 45 |
|
|
2018
Q1 | $10.4M | Sell |
125,065
-13,759
| -10% | -$1.14M | 0.61% | 56 |
|
|
2017
Q4 | $10.8M | Buy |
+138,824
| New | +$10.8M | 0.54% | 57 |
|